Stephen J. Forman, Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT.OB), bought 100,000 shares at $0.50 ($50K) on 2018-12-07, disclosed to the SEC on 2018-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.